Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is now displayed. The prior v3.4.1 notice about government funding lapses has been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a system notice about a lapse in government funding. Updated the page revision to v3.4.1 (from v3.4.0).SummaryDifference0.2%

- Check28 days agoChange DetectedGlossary toggle added for user help. Footer/meta labels updated, including case changes, removal of the Estimated tag, and the new revision version.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No changes to study content or criteria are observed.SummaryDifference0.0%

- Check63 days agoChange DetectedExpanded the study locations to include additional sites across the US and Canada (e.g., Alabama, Alaska, Ontario, Quebec). The revision was updated to v3.3.3.SummaryDifference2%

- Check70 days agoChange DetectedDifference0.1%

Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.